These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10989724)

  • 21. Pharmacokinetics of intravenously administered pefloxacin in the prostate; perspectives for its application in surgical prophylaxis.
    Giannopoulos A; Koratzanis G; Giamarellos-Bourboulis EJ; Stinios I; Chrisofos M; Giannopoulou M; Giamarellou H
    Int J Antimicrob Agents; 2001 Mar; 17(3):221-4. PubMed ID: 11282268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of peritonitis related to chronic ambulatory peritoneal dialysis (CAPD) using two daily intraperitoneal injections of 400 mg pefloxacin.
    Ragnaud JM; Roche-Bezian MC; Dupon M; Wone C
    Chemioterapia; 1987 Jun; 6(2 Suppl):481-3. PubMed ID: 3509476
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of norfloxacin or pefloxacin on the oral and intestinal microflora of bone marrow transplant patients.
    Giuliano M; Gentile G; Pantosti A; Micozzi A; Arcese W; Martino P
    J Chemother; 1989 Jul; 1(4 Suppl):726-7. PubMed ID: 16312609
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pefloxacine and severe eye infections].
    Massin-Cochereau I; Le Hoang P; Weiser M; Rousselie F
    Bull Soc Ophtalmol Fr; 1987; 87(6-7):735-6, 738. PubMed ID: 3499243
    [No Abstract]   [Full Text] [Related]  

  • 25. [In vitro activity of 3 fluoroquinolones on Branhamella catarrhalis].
    Suermondt G; Denamur E; Laurans G; Orfila J
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):647-50. PubMed ID: 3141885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and pharmacokinetic study of pefloxacin in spontaneous ascitic fluid infections].
    Ducroix JP; Hary L; Andrejak M; Smail A; Tondriaux A; Eb F; Baillet J
    Therapie; 1990; 45(6):461-5. PubMed ID: 2080483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The new quinolones].
    Lontie M
    J Pharm Belg; 1989; 44(4):292-301. PubMed ID: 2691640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic contribution of the new quinolones].
    Wolff M
    Rev Prat; 1987 Apr; 37(21):1209-14. PubMed ID: 3474759
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical and laboratory investigation of pefloxacin used prophylactically in operations on the liver].
    Khlebnikov EP; Vishnevskiĭ VA; Kubyshkin VA; Terekhova RP
    Antibiot Khimioter; 2009; 54(3-4):32-7. PubMed ID: 19711848
    [No Abstract]   [Full Text] [Related]  

  • 30. Report: pharmacokinetic and drug interaction studies of pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan.
    Gauhar S; Ali SA; Naqvi SB; Shoaib MH
    Pak J Pharm Sci; 2014 Mar; 27(2):389-95. PubMed ID: 24577931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serious, life-threatening infections: results with pefloxacin.
    Gargalianos P; Lelekis M; Lanaras L; Karakatsani E; Tsouroulas P; Kosmidis J
    J Chemother; 1989 Jul; 1(4 Suppl):672-3. PubMed ID: 16312586
    [No Abstract]   [Full Text] [Related]  

  • 32. Pefloxacin penetration into human necrotic pancreatic tissue.
    Bertazzoni Minelli E; Benini A; Muner A; Bassi C; Abbas H; Pederzoli P
    J Antimicrob Chemother; 1996 Aug; 38(2):237-43. PubMed ID: 8877537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial symposium. Part 1. Principles of antimicrobial therapy.
    Greenfield RA; Cooper TW; Bronze MS
    J Okla State Med Assoc; 2006 Sep; 99(9):474-9. PubMed ID: 17087070
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics of pefloxacin in human prostatic tissue.
    Salpigides G; Pangalis A; Kouvelas D; Paradelis AG
    J Chemother; 1995 Nov; 7 Suppl 4():105-6. PubMed ID: 8904124
    [No Abstract]   [Full Text] [Related]  

  • 35. Quinolone antimicrobial agents in acute exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Teengs JP; Baur C
    Eur J Respir Dis Suppl; 1986; 146():585-90. PubMed ID: 3465584
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative effect of gentamicin and pefloxacin treatment on the late stages of mouse typhoid.
    Bonina L; Costa GB; Mastroeni P
    New Microbiol; 1998 Jan; 21(1):9-14. PubMed ID: 9497924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fluoroquinolones and their importance in modern chemotherapy of infectious diseases].
    Padeĭskaia EN
    Antibiot Khimioter; 1989 Jul; 34(7):514-21. PubMed ID: 2818083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pefloxacin in the treatment of 24 suppurative infections.
    Desplaces N; Mamoudy P; Leonard P; Houdart R; Rouchy J; Kitzis M; Gutmann L
    Chemioterapia; 1987 Jun; 6(2 Suppl):394-5. PubMed ID: 3509457
    [No Abstract]   [Full Text] [Related]  

  • 39. Pefloxacin versus cefuroxime axetil for single-dose therapy of acute uncomplicated lower urinary tract infections in women.
    Krcmery S; Hromec J; Gulla D
    J Chemother; 1995 Nov; 7 Suppl 4():168-9. PubMed ID: 8904145
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effectiveness of pefloxacin in brucellosis].
    Kurmanova KB; Kkhamfyang S; Iudin SM
    Antibiot Khimioter; 1995 Jul; 40(7):39-42. PubMed ID: 8645059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.